Recombinant Human Activated Protein C Resets Thrombin Generation in Patients With Severe Sepsis -- A Case Control Study
5th Sep 2005, 13:53 GMT
The dynamics of the anticoagulant, anti-inflammatory and pro-fibrinolytic action of rhAPC in patients with severe sepsis, by comparing rhAPC-treated patients with case controls is investigated. Critical Care
Latest news from Medscape Internal Medicine Headlines:
- National Medical Association 2006 Annual Convention and Scientific Assembly
- Highlights of National Medical Association 2006 Annual Convention and Scientific Assembly
- PSA Screening May Not Be Warranted in Elderly Men With Limited Life Expectancy
- Weight Loss Improves Glucose Tolerance in Nonobese, Healthy Adults
- Depressed Men Have Lower Testosterone Levels
- Canadian Study Indicates BNP Test for Suspected Feart Failure is Cost-effective
- Multiple Sclerosis (MS) of the Spinal Cord
- A Survey of Neurologists on Bothersome Patient Behaviors
- Brand-Name Buying Drugs Fuels Boom in Overall Drug Spending
- The Middle Way: A Practical Approach to Prescribing Opioids for Chronic Pain